A Review of the Knops Blood Group System

Area of Science:

• Immunogenetics
• Hematology
• Molecular Biology

Background:

• The Knops blood group system, recognized in 1992, comprises 13 antigens on the Complement C3b/C4b Receptor 1 (CR1) glycoprotein.
• CR1, a member of the receptors of complement activation (RCA) family, is encoded by a gene on chromosome 1 and plays a crucial role in erythrocyte immune functions.
• Polymorphisms in CR1 expression are linked to various diseases, including systemic lupus erythematosus, malaria, Alzheimer's disease, and leprosy.

Purpose of the Study:

• To review the advancements and current understanding of the Knops blood group system.
• To highlight the significance of CR1 in erythrocyte immunity and its association with diseases.
• To discuss the clinical implications of anti-Knops antibodies, particularly in pregnant women.

Main Methods:

• Literature review of studies on the Knops blood group system and CR1.
• Analysis of the genetic and molecular basis of Knops antigens.
• Review of clinical case studies and serological findings related to anti-Knops antibodies.

Main Results:

• The Knops system consists of 13 antigens carried by the CR1 protein, a key regulator of complement activation.
• CR1's role in erythrocyte immune response is critical, and its variations are associated with significant health conditions.
• Anti-Knops antibodies are generally non-hemolytic but can be detected in pregnant women, with rare implications for hemolytic disease of the newborn.

Conclusions:

• The Knops blood group system, mediated by CR1, is integral to erythrocyte immune function and disease pathogenesis.
• Further research into CR1 polymorphisms and anti-Knops antibodies can improve understanding and clinical management.
• This review consolidates current knowledge on the Knops system, emphasizing its clinical relevance.